MedPath

The effect of protein preloads” on postprandial glycaemia in type 2 diabetes: a 12-week, single-blind, randomised and placebo-controlled trial.

Phase 2
Completed
Conditions
Type 2 diabetes mellitus
Diet and Nutrition - Other diet and nutrition disorders
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12614001131640
Lead Sponsor
niversity of Adelaide
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
70
Inclusion Criteria

Type 2 diabetes, managed with diet or metformin alone
- HbA1c between 6.0% and 7.9% inclusive
- Body mass index 19-40
- Weight stable

Exclusion Criteria

- Significant gastrointestinal symptoms, or history of gastrointestinal disease
- Proteinuria
- Use of medications likely to affect gastrointestinal function

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glycated haemoglobin (HbA1c) - difference in the change in HbA1c after the intervention between active treatment and placebo[12 weeks]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath